E-LIB Suche - Ergebnisse für: Barkay, Hadas

1

Deutetrabenazine Provides Long-Term Benefit for Tardive Dys..:

Hauser, Robert A. ; Barkay, Hadas ; Fernandez, Hubert H....
Journal of Clinical Psychopharmacology. , 2024

Link: https://doi.org/10.1097/..

2

Safety of Deutetrabenazine for the Treatment of Tardive Dys..:

Frank, Samuel ; Anderson, Karen E. ; Fernandez, Hubert H....
Neurology and Therapy. 13 (2024) 3 - p. 655-675 , 2024

Link: https://doi.org/10.1007/..

3

Safety and Efficacy of Long‐Term Deutetrabenazine Use in Ch..:

Jankovic, Joseph ; Coffey, Barbara ; Claassen, Daniel O....
Movement Disorders Clinical Practice. 10 (2023) 9 - p. 1388-1398 , 2023

Link: https://doi.org/10.1002/..

4

Effects of Long-Term Deutetrabenazine Treatment in Patients..:

Hauser, Robert A. ; Barkay, Hadas ; Fernandez, Hubert H....
CNS Spectrums. 27 (2022) 2 - p. 245-246 , 2022

Link: https://doi.org/10.1017/..

5

Effects of Long-Term Deutetrabenazine Treatment in Patients..:

Gordon, Mark Forrest ; Hauser, Robert A. ; Barkay, Hadas...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

6

Long-Term Efficacy and Safety of Deutetrabenazine in Patien..:

Barkay, Hadas ; Hauser, Robert A. ; Fernandez, Hubert H....
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

7

Dose Patterns for Long-Term Deutetrabenazine Treatment in P..:

Barkay, Hadas ; Finkbeiner, Stacy ; Wilhelm, Amanda...
CNS Spectrums. 27 (2022) 2 - p. 239-240 , 2022

Link: https://doi.org/10.1017/..

8

Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia..:

Hauser, Robert A. ; Barkay, Hadas ; Fernandez, Hubert H....
Frontiers in Neurology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

9

Dose Patterns for Long-Term Deutetrabenazine Treatment in P..:

Barkay, Hadas ; Finkbeiner, Stacy ; Wilhelm, Amanda...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

10

Long-Term Safety and Efficacy of Deutetrabenazine in Younge..:

Sajatovic, Martha ; Finkbeiner, Stacy ; Wilhelm, Amanda...
The American Journal of Geriatric Psychiatry. 30 (2022) 3 - p. 360-371 , 2022

Link: https://doi.org/10.1016/..

11

Minimal clinically important change in Abnormal Involuntary..:

Hauser, Robert A. ; Barkay, Hadas ; Wilhelm, Amanda...
Parkinsonism & Related Disorders. 97 (2022) - p. 47-51 , 2022

Link: https://doi.org/10.1016/..

12

Long-Term Efficacy and Safety of Deutetrabenazine in Patien..:

Hauser, Robert A. ; Barkay, Hadas ; Fernandez, Hubert H....
CNS Spectrums. 27 (2022) 2 - p. 246-246 , 2022

Link: https://doi.org/10.1017/..

13

Long-Term Deutetrabenazine Treatment Is Associated With Con..:

Hauser, Robert A. ; Barkay, Hadas ; Fernandez, Hubert H....
CNS Spectrums. 26 (2021) 2 - p. 162-162 , 2021

Link: https://doi.org/10.1017/..

14

Minimal Clinically Important Difference in AIMS Score Based..:

Barkay, Hadas ; Hauser, Robert A. ; Wilhelm, Amanda...
CNS Spectrums. 26 (2021) 2 - p. 159-159 , 2021

Link: https://doi.org/10.1017/..

15

Comparison of Safety and Tolerability of Deutetrabenazine D..:

Wilhelm, Amanda ; Anderson, Karen E. ; Fernandez, Hubert H....
CNS Spectrums. 26 (2021) 2 - p. 164-164 , 2021

Link: https://doi.org/10.1017/..